{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:25:46Z","timestamp":1789104346354,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.dadr.2024.100268","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:36:26Z","timestamp":1723595786000},"page":"100268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Synthetic opioids have disrupted conventional wisdom for treating opioid overdose"],"prefix":"10.1016","volume":"12","author":[{"given":"Phil","family":"Skolnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Paavola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Heidbreder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dadr.2024.100268_bib1","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1080\/08897077.2021.2010252","article-title":"The need for multiple naloxone administrations for opioid overdose reversals: a review of the literature","volume":"43","author":"Abdelal","year":"2022","journal-title":"Subst. Abus."},{"key":"10.1016\/j.dadr.2024.100268_bib2","unstructured":"Ahmad FB, C.J., Rossen L.M., Sutton P., 2024. Provisional drug overdose death counts. National Center for Health Statistics, \u3008https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm\u3009 (accessed 28 July 2024)."},{"key":"10.1016\/j.dadr.2024.100268_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11524-024-00852-0","article-title":"Overdose from unintentional fentanyl use when intending to use a non-opioid substance: an analysis of medically attended opioid overdose events","volume":"101","author":"Bazazi","year":"2024","journal-title":"J. Urban Health"},{"issue":"5","key":"10.1016\/j.dadr.2024.100268_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/ADM.0000000000001185","article-title":"Fentanyl absorption, distribution, metabolism, and excretion: narrative review and clinical significance related to illicitly manufactured fentanyl","volume":"17","author":"Bird","year":"2023","journal-title":"J. Addict. Med."},{"issue":"2","key":"10.1016\/j.dadr.2024.100268_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMra1202561","article-title":"Management of opioid analgesic overdose","volume":"367","author":"Boyer","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dadr.2024.100268_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110955","article-title":"Overdose deaths involving synthetic opioids: racial\/ethnic and educational disparities in the eastern and western US","volume":"251","author":"Cano","year":"2023","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.dadr.2024.100268_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13181-019-00735-w","article-title":"Naloxone dosing after opioid overdose in the era of illicitly manufactured fentanyl","volume":"16","author":"Carpenter","year":"2020","journal-title":"J. Med. Toxicol."},{"issue":"1-3","key":"10.1016\/j.dadr.2024.100268_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2005.08.008","article-title":"3)H]Alvimopan binding to the mu-opioid receptor: comparative binding kinetics of opioid antagonists","volume":"520","author":"Cassel","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.dadr.2024.100268_bib9","unstructured":"Centers for Disease Control and Prevention, 2020. CDC Health Advisory: Increase in Fatal Drug Overdoses Across the United States Driven by Synthetic Opioids Before and During the COVID-19 Pandemic. \u3008https:\/\/archive.cdc.gov\/emergency_cdc_gov\/han\/2020\/han00438.asp\u3009 (accessed 20 July 2024)."},{"key":"10.1016\/j.dadr.2024.100268_bib10","unstructured":"Centers for Disease Control and Prevention, 2024. Data from: State Unintentional Drug Overdose Reporting System (SUDORS). \u3008https:\/\/www.cdc.gov\/overdose-prevention\/data-research\/facts-stats\/sudors-dashboard-fatal-overdose-data.html\u3009 (accessed 15 May 2024)."},{"issue":"1","key":"10.1016\/j.dadr.2024.100268_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cpdd.1312","article-title":"Pharmacokinetic Properties of an FDA-approved Intranasal Nalmefene Formulation for the Treatment of Opioid Overdose","volume":"13","author":"Crystal","year":"2024","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"1","key":"10.1016\/j.dadr.2024.100268_bib12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","article-title":"Incidence, reversal, and prevention of opioid-induced respiratory depression","volume":"112","author":"Dahan","year":"2010","journal-title":"Anesthesiology"},{"issue":"9","key":"10.1016\/j.dadr.2024.100268_bib13","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/add.13429","article-title":"The toxicology of heroin-related death: estimating survival times","volume":"111","author":"Darke","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2024.100268_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.2421","article-title":"Reversal of Opioid-Induced Respiratory Depression in Healthy Volunteers: comparison of Intranasal Nalmefene and Intranasal Naloxone","author":"Ellison","year":"2024","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.dadr.2024.100268_bib15","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, 2024. European Drug Report 2024: Trends and Developments \u3008https:\/\/www.emcdda.europa.eu\/publications\/european-drug-report\/2024_en\u3009"},{"issue":"2","key":"10.1016\/j.dadr.2024.100268_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1056\/NEJMp2312084","article-title":"The overdose crisis among U.S. Adolescents","volume":"390","author":"Friedman","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.dadr.2024.100268_bib17","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/bja\/aes029","article-title":"Intravenous boluses of fentanyl, 1 mug kg(-)(1), and remifentanil, 0.5 mug kg(-)(1), give similar maximum ventilatory depression in awake volunteers","volume":"108","author":"Gelberg","year":"2012","journal-title":"Br. J. Anaesth."},{"issue":"6","key":"10.1016\/j.dadr.2024.100268_bib18","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1097\/00000542-199906000-00010","article-title":"Determination of the potency of remifentanil compared with alfentanil using ventilatory depression as the measure of opioid effect","volume":"90","author":"Glass","year":"1999","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.dadr.2024.100268_bib19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1213\/00000539-199403000-00021","article-title":"Comparison of potency and duration of action of nalmefene and naloxone","volume":"78","author":"Glass","year":"1994","journal-title":"Anesth. Analg."},{"issue":"10","key":"10.1016\/j.dadr.2024.100268_bib20","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jamainternmed.2016.4310","article-title":"Counterfeit medications and fentanyl","volume":"176","author":"Green","year":"2016","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.dadr.2024.100268_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/1742-6723.13344","article-title":"One single large intramuscular dose of naloxone is effective and safe in suspected heroin poisoning","volume":"32","author":"Harris","year":"2020","journal-title":"Emerg. Med. Austral"},{"issue":"2","key":"10.1016\/j.dadr.2024.100268_bib22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bph.14860","article-title":"Fentanyl depression of respiration: comparison with heroin and morphine","volume":"177","author":"Hill","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.dadr.2024.100268_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103457","article-title":"Increasingly powerful opioid antagonists are not necessary","volume":"99","author":"Hill","year":"2022","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100268_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104323","article-title":"Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement","volume":"124","author":"Infante","year":"2024","journal-title":"Int. J. Drug Policy"},{"issue":"3","key":"10.1016\/j.dadr.2024.100268_bib25","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/S2468-2667(21)00304-2","article-title":"Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study","volume":"7","author":"Irvine","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.dadr.2024.100268_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuropharm.2019.02.008","article-title":"Respiratory depression and brain hypoxia induced by opioid drugs: morphine, oxycodone, heroin, and fentanyl","volume":"151","author":"Kiyatkin","year":"2019","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.dadr.2024.100268_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adaw.34010","article-title":"FDA urges reevaluating naloxone dosing in fentanyl era","volume":"36","author":"Knopf","year":"2024","journal-title":"Alcohol. Drug Abus. Wkly."},{"issue":"3","key":"10.1016\/j.dadr.2024.100268_bib28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/bja\/61.3.318","article-title":"Antagonism of morphine-induced respiratory depression with nalmefene","volume":"61","author":"Konieczko","year":"1988","journal-title":"Br. J. Anaesth."},{"issue":"10","key":"10.1016\/j.dadr.2024.100268_bib29","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/jcph.759","article-title":"Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose","volume":"56","author":"Krieter","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.dadr.2024.100268_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1399803","article-title":"Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on cardiac adrrest","volume":"15","author":"Laffont","year":"2024","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.dadr.2024.100268_bib31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/ALN.0000000000004622","article-title":"Opioid overdose: limitations in naloxone reversal of respiratory depression and prevention of cardiac arrest","volume":"139","author":"van Lemmen","year":"2023","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.dadr.2024.100268_bib32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s13181-016-0591-3","article-title":"In response to: \"the evolution of recommended naloxone dosing for opioid overdose by medical specialty","volume":"12","author":"Lombardi","year":"2016","journal-title":"J. Med. Toxicol."},{"issue":"5","key":"10.1016\/j.dadr.2024.100268_bib33","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/cpt.2696","article-title":"Development of a translational model to assess the impact of opioid overdose and naloxone dosing on respiratory depression and cardiac arrest","volume":"112","author":"Mann","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.dadr.2024.100268_bib34","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/add.14033","article-title":"Pharmacokinetics of concentrated naloxone nasal spray for opioid overdose reversal: phase I healthy volunteer study","volume":"113","author":"McDonald","year":"2018","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.dadr.2024.100268_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234683","article-title":"Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level","volume":"15","author":"Moss","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.dadr.2024.100268_bib36","series-title":"Illegal synthetic opioids: Can Europe prevent a crisis?","author":"Pardal","year":"2024"},{"key":"10.1016\/j.dadr.2024.100268_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.111062","article-title":"Examination of naloxone dosing patterns for opioid overdose by emergency medical services in Kentucky during increased fentanyl use from 2018 to 2021","volume":"255","author":"Rock","year":"2024","journal-title":"Drug Alcohol Depen"},{"key":"10.1016\/j.dadr.2024.100268_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40262-024-01355-6","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Naloxone","volume":"63","author":"Saari","year":"2024","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.dadr.2024.100268_bib39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/15563650701877374","article-title":"Fentanyl epidemic in Chicago, Illinois and surrounding Cook County","volume":"46","author":"Schumann","year":"2008","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.dadr.2024.100268_bib40","article-title":"Psychostimulant drug co-ingestion in non-fatal opioid overdose","volume":"10","author":"Shastri","year":"2024","journal-title":"Drug Alcohol Depen. Rep."},{"key":"10.1016\/j.dadr.2024.100268_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2018.08.004","article-title":"On the front lines of the opioid epidemic: rescue by naloxone","volume":"835","author":"Skolnick","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.dadr.2024.100268_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108019","article-title":"Treatment of overdose in the synthetic opioid era","volume":"233","author":"Skolnick","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"14","key":"10.1016\/j.dadr.2024.100268_bib43","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","article-title":"Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016","volume":"66","author":"Somerville","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"11","key":"10.1016\/j.dadr.2024.100268_bib44","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1080\/15563650.2023.2283391","article-title":"American College of Medical Toxicology and the American Academy of Clinical Toxicology position statement: nalmefene should not replace naloxone as the primary opioid antidote at this time","volume":"61","author":"Stolbach","year":"2023","journal-title":"Clin. Toxicol."},{"issue":"1","key":"10.1016\/j.dadr.2024.100268_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.51839","article-title":"Intranasal naloxone repeat dosing strategies and fentanyl overdose: a simulation-based randomized clinical trial","volume":"7","author":"Strauss","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2024.100268_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103751","article-title":"Patient perceptions of higher-dose naloxone nasal spray for opioid overdose","volume":"106","author":"Strickland","year":"2022","journal-title":"Int. J. Drug Policy"},{"issue":"1","key":"10.1016\/j.dadr.2024.100268_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/acem.13034","article-title":"Fatal fentanyl: one pill can kill","volume":"24","author":"Sutter","year":"2017","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.dadr.2024.100268_bib48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","article-title":"A review: fentanyl and non-pharmaceutical fentanyls","volume":"171","author":"Suzuki","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.dadr.2024.100268_bib49","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJMc2313270","article-title":"Increasing exposure of young children to illicit fentanyl in the United States","volume":"390","author":"Temple","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dadr.2024.100268_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/26331055241247156","article-title":"Collateral damage: neurological correlations of non-fatal overdose in the era of fentanyl-xylazine","volume":"19","author":"Todaro","year":"2024","journal-title":"Neurosci. Insights"},{"key":"10.1016\/j.dadr.2024.100268_bib51","first-page":"440","article-title":"Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications","volume":"178","author":"Toll","year":"1998","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.dadr.2024.100268_bib52","unstructured":"United States Drug Enforcement Administration, 2024. One Pill Can Kill. \u3008https:\/\/www.dea.gov\/onepill\u3009 (accessed 28 July 2024)."},{"issue":"4","key":"10.1016\/j.dadr.2024.100268_bib53","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMsr1706626","article-title":"The role of science in the opioid crisis","volume":"377","author":"Volkow","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1-2","key":"10.1016\/j.dadr.2024.100268_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/15563659809162577","article-title":"Opioid toxicity recurrence after an initial response to naloxone","volume":"36","author":"Watson","year":"1998","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.dadr.2024.100268_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108838","article-title":"Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: a systematic review","volume":"226","author":"Winstanley","year":"2021","journal-title":"Drug Alcohol Depend."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T17:56:25Z","timestamp":1732643785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724624000520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":55,"alternative-id":["S2772724624000520"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100268","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic opioids have disrupted conventional wisdom for treating opioid overdose","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100268","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100268"}}